Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?

The most common subtype of ovarian cancer (OC) is the high-grade serous ovarian carcinoma (HGSOC), accounting for 70%–80% of all OC deaths. Although HGSOC is a potentially immunogenic tumor, clinical studies assessing the effectiveness of inhibitors of programmed death protein and its ligand (PD-1/P...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanale, Daniele, Corsini, Lidia Rita, Brando, Chiara, Cutaia, Sofia, Di Donna, Mariano Catello, Filorizzo, Clarissa, Lisanti, Maria Chiara, Randazzo, Ugo, Magrin, Luigi, Romano, Raffaella, Bazan Russo, Tancredi Didier, Olive, Daniel, Vieni, Salvatore, Pantuso, Gianni, Chiantera, Vito, Russo, Antonio, Bazan, Viviana, Iovanna, Juan Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532861/
https://www.ncbi.nlm.nih.gov/pubmed/36212445
http://dx.doi.org/10.3389/fonc.2022.946319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532861/
https://www.ncbi.nlm.nih.gov/pubmed/36212445
http://dx.doi.org/10.3389/fonc.2022.946319

Ejemplares similares